What are the potentials and ethical challenges that CRISPR-Cas9 technology is opening up in modern medicine?
CRISPR-Cas9, a revolutionary gene-editing tool, allows scientists to precisely cut and paste DNA sequences. This capability opens vast possibilities for medicine, but also brings significant ethical dilemmas.
Ian James Martins
The potentials and ethical challenges that CRISPR-Cas9 technology may need to determine in modern medicine is associated with the inactivation of the anti-aging gene Sirtuin 1 or other anti-aging genes. CRISPR-Cas9 technology may need to activate the anti-aging genes to promote health and well being in modern medicine.
RELEVANT REFERENCES:
1. Anti-Aging Genes Improve Appetite Regulation and Reverse Cell Senescence and Apoptosis in Global Populations. Advances in Aging Research, 2016, 5, 9-26.
2. Single Gene Inactivation with Implications to Diabetes and Multiple Organ Dysfunction Syndrome. J Clin Epigenet. 2017. Vol. 3 No. 3:24.
3. Sirtuin 1, a Diagnostic Protein Marker and its Relevance to Chronic Disease and Therapeutic Drug Interventions”. EC Pharmacology and Toxicology 6.4 (2018): 209-215.
ESRA
1. Gacita AM, Fullenkamp DE, Ohiri J, Pottinger T, Puckelwartz MJ, Nobrega MA, et al. Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression. Circulation. 2021;143:1302–1316.